Expression of Immune Checkpoint Molecules in Endometrial Carcinoma

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2015.2714
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Immune Checkpoint Inhibition: From Molecules to Clinical Application

Clinical and Experimental Immunology
AllergyImmunology
2020English

Expression of Bc-L2 in Precancerous Endometrial Lesion and Endometrial Carcinoma

Sohag Medical Journal
2019English

Hypomethylation-Induced Expression of S100A4 in Endometrial Carcinoma

Modern Pathology
Forensic MedicinePathology
2007English

Comprehensive Immunohistochemical Analysis of Immune Checkpoint Molecules in Adult T-Cell Leukemia/Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Expression of EZH2 in Endometrial Carcinoma and Its Effects on Proliferation and Invasion of Endometrial Carcinoma Cells

Oncology Letters
Cancer ResearchOncology
2017English

Urocortin Expression Is Downregulated in Human Endometrial Carcinoma

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2006English

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Efficacy and Safety of Immune Checkpoint Therapy in Hepatocellular Carcinoma: Meta-Analysis

Hepatoma Research
2019English

PINCH Protein Expression in Normal Endometrium, Atypical Endometrial Hyperplasia and Endometrioid Endometrial Carcinoma

Chemotherapy
MedicineDrug DiscoveryInfectious DiseasesOncologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy